$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
卡麦角林怎么样?
2025-10-19 11:44:20
Check Details
普拉克索:为帕金森病患者提供更稳定的疗效
2025-10-19 11:44:20
Check Details
雷沙吉兰的功效与作用及副作用介绍
2025-10-19 11:44:20
Check Details
雷沙吉兰能治好早期帕金森病吗?
2025-10-19 11:44:20
Check Details
普拉克索:帕金森病治疗的新进展
2025-10-19 11:44:20
Check Details
普拉克索:帕金森病治疗的创新选择
2025-10-19 11:44:20
Check Details
服用沙芬酰胺的效果及作用机制简介
2025-10-19 11:44:20
Check Details
奥匹卡朋的上市时间及作用效果介绍
2025-10-19 11:44:20
Check Details
全球首款帕金森病吸入治疗药物:Inbrija
2025-10-19 11:44:20
Check Details
奥匹卡朋导致的不良反应怎么治疗
2025-10-19 11:44:20
Check Details
奥匹卡朋全网公布的2024年的最新价格
2025-10-19 11:44:20
Check Details
帕金森药物雷沙吉兰的副作用及处理和注意事项简介
2025-10-19 11:44:20
Check Details
1
2
...
3390
3391
3392
3393
3394
3395
3396
...
10230
10231
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Selpercatinib: Dosing and Administration Essentials of an Oral RET Inhibitor
2
Enasidenib: A Targeted IDH2 Inhibitor for Acute Myeloid Leukemia
3
Alpelisib: From Breast Cancer to PIK3CA-Related Overgrowth Spectrum
4
Ponatinib in Chronic Myeloid Leukemia: 5-Year Results from the OPTIC Trial
5
Erdafitinib Oral Tablets: Strengths, Packaging, and Dose Adjustment
6
Capmatinib (Tabrecta): Oral Targeted Therapy for MET Exon 14 Skipping-Mutated NSCLC
7
Amivantamab Plus Lazertinib: A Chemotherapy-Free First-Line Option in EGFR-Mutated NSCLC
8
Midostaurin (Rydapt): Dosing Essentials in FLT3-Mutated AML and Systemic Mastocytosis
9
Lapatinib: An Oral Dual EGFR/HER2 TKI in HER2-Positive Breast Cancer
10
Filgotinib (Jyseleca) Overseas Guide: JAK1 Inhibitor for Rheumatoid Arthritis and Ulcerative Colitis
11
FDA Approves LISRAYA (brepocitinib): First Oral Targeted Therapy for Adults with Dermatomyositis
12
Elagolix for Endometriosis Pain: Indications and Usage Guidelines